High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)

Clinical trial NCT00050531 · COMPLETED

Trial details

NCT number: NCT00050531
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Myeloid, Chronic

Start date: 2003-04-01
Primary completion: 2007-04-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.